ErtemAGEfeTHYaylaC. The Association Between Serum Procalcitonin Levels and Severity of Coronary Artery Disease Assessed by SYNTAX Score in Patients With Acute Coronary Syndrome. Angiology. 2017;68(1):40–45.
2.
FarooqVvan KlaverenDSteyerbergEW. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381(9867):639–650.
3.
SerruysPWMoriceMCKappeteinAP; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–972.
4.
MohrFWMoriceMCKappeteinAP. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629–638.
5.
GenereuxPPalmeriniTCaixetaA. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J Am Coll Cardiol. 2012;59(24):2165–2174.
6.
MagroMRaberLHegD. The MI SYNTAX score for risk stratification in patients undergoing primary percutaneous coronary intervention for treatment of acute myocardial infarction: a substudy of the COMFORTABLE AMI trial. Int J Cardiol. 2014;175(2):314–322.
7.
BogatyPPoirierPSimardSBoyerLSolymossSDagenaisGR. Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation. 2001;103(25):3062–3068.
8.
AnnbornMDankiewiczJErlingeD. Procalcitonin after cardiac arrest - an indicator of severity of illness, ischemia-reperfusion injury and outcome. Resuscitation. 2013;84(6):782–787.
9.
LoncarGTschollVTahirovicE. Should procalcitonin be measured routinely in acute decompensated heart failure?Biomark Med. 2015;9(7):651–659.
10.
BrunkhorstFMClarkALForyckiZFAnkerSD. Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol. 1999;72(1):3–10.
